絞り込み

16599

広告

1239件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?

Would the Use of Edoxaban Be Cost-effective for the Prevention of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation in Spain?

In vitro assessment of edoxaban anticoagulant effect in pediatric plasma.

Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation.

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol.

Edoxaban improves atrial fibrillation and thromboembolism through regulation of the Wnt-β-induced PI3K/ATK-activated protein C system.

Update in Hospital Medicine: Practical Lessons from Current Literature.

Popliteal Artery Entrapment Syndrome (PAES) in a 17-Year-Old Adolescent.

Update on catheter ablation research from the 2019 ehra congress.

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.

A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.

Consensus in cardiology on non-vitamin k oral anticoagulants for patients with atrial fibrillation.

A review of reversal of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery.

Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants used in Atrial Fibrillation.

Anticoagulation of Cardiovascular Conditions in the Cancer Patient: Review of Old and New Therapies.

Uninterrupted non-vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation.

Improved enantioselectivity of E. coli BioH in kinetic resolution of methyl (S)-3-cyclohexene-1-carboxylate by combinatorial modulation of steric and aromatic interactions.

Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: Update and Periprocedural Management.

Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります